Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas
Zika virus remains a major public health concern because of its association with microcephaly and other neurologic disorders in newborns. A prophylactic vaccine has the potential to reduce disease incidence and eliminate birth defects resulting from prenatal Zika virus infection in future outbreaks....
Main Authors: | Affan Shoukat, Thomas Vilches, Seyed M. Moghadas |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2019-12-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/25/12/18-1324_article |
Similar Items
-
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia
by: Affan Shoukat, et al.
Published: (2018-07-01) -
Zika Virus - An Overview
by: Rumela Ghosh, et al.
Published: (2016-09-01) -
Complete coding sequence of Zika virus from Martinique outbreak in 2015
by: G. Piorkowski, et al.
Published: (2016-05-01) -
Zika Virus Infection and Microcephaly
by: J. Gordon Millichap
Published: (2016-03-01) -
Microcephaly caused by the Zika virus: dental care
by: Juliana da Silva MORO, et al.
Published: (2019-04-01)